Onesource Specialty Pharma Limited
Amansa Holdings decreased its stake in Onesource Specialty Pharma Limited from 1.86% to 1.58%. The fund sold 3,14,836 shares, reducing its holding to 18,17,076 shares.
A specialist pharmaceutical company engaged in the research, development, and manufacturing of biological drug products in injectable formats for therapeutic use. OneSource Specialty Pharma provides comprehensive contract development and manufacturing organization services spanning all phases of preclinical and clinical development, alongside commercial supply of biologics to domestic and international pharmaceutical clients and healthcare providers.
Singapore-based India-dedicated equity fund founded in 2006 by Akash Prakash (ex-GIC, ex-Temasek India). Concentrated long-only strategy with ~20 listed positions and a disclosed book value of roughly Rs 17,000 cr across names like GMM Pfaudler, Fortis Healthcare, V-Mart Retail and Eicher Motors. One of the original India-only foreign hedge funds, with ~USD 1 bn+ in assets.